AFFILIATE STOCK PURCHASE AGREEMENT


          THIS AFFILIATE STOCK PURCHASE
AGREEMENT
(“Agreement”) is made as of the 6th day of
May, 2009, by and between WALTER
BRENNER (“Seller”) and TELEMEDICINE, INC. (“Purchaser”) as to 3,000,000 shares,
of ANVIL FOREST PRODUCTS, INC. 


RECITALS


          WHEREAS,
the Seller is the owner of 3,000,000
restricted shares of common stock of ANVIL
FOREST PRODUCTS, INC., a NEVADA corporation (the “Company”); and


          WHEREAS,
the Seller proposes to sell to the Purchaser the 3,000,000 restricted shares of
common stock of the Company currently owned
by the Seller (the “Purchased Shares”), on the terms set forth herein.


          In
consideration of the premises, representations, warranties and covenants
contained herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows:


	
 

	
 


	
1.

	
PURCHASE AND SALE AND CLOSING





1.1               The
Seller hereby agrees to sell, assign, transfer
and deliver to the Purchaser, and the
Purchaser hereby agrees to purchase from the Seller, the Purchased Shares for
the purchase price of TWENTY NINE
THOUSAND FIVE HUNDRED EIGHT and no/100 U.S. Dollars ($29,508) (the “Purchase Price”). Payment shall be
in U.S. Dollars, in the form of cash or check as follows. An amount of
$29,508 in good funds delivered and cleared to Seller’s account via escrow agent WILLIAM R. BARKER, PA (“Escrow Agent”)
(account information as provided by
separate communiqué’).


1.2               Closing.
The closing (“Closing”) of the transactions contemplated hereby will occur on, or, before the 6th day of May, 2009 (the
“Closing Date”).


	
 

	
 


	
2.

	
REPRESENTATIONS
 AND WARRANTIES OF THE SELLER





2.1               The
Seller warrants, covenants and represents to
the Purchaser with the intention of inducing the Purchaser to enter into
this Agreement that:


	
 

	
 

	
 


	
 

	
(a)

	
immediately prior to and at
 the Closing, the Seller shall be the legal and beneficial owner of
 the Purchased Shares and on the Closing Date, the Seller shall transfer to the Purchaser the Purchased Shares free and
 clear of all liens, restrictions, covenants or adverse claims of any
 kind or character;


	
 

	
 

	
 


	
 

	
(b)

	
the Seller has the legal power and authority to
 execute and deliver this Agreement and all
 other documents required to be executed and delivered by the Seller hereunder and to consummate the transactions
 contemplated hereby; and





Page 1 of 5


ASPA1












	
 

	
 

	
 


	
 

	
(c)

	
the
 Seller is, or has been during the past ninety (90) days, an officer,
 director, 10% or greater shareholder or
 “affiliate” of the Company, as that term is defined in Rule 144 promulgated under the United States
 Securities Act of 1933, as amended
 (the “Securities Act”);


	
 

	
 

	
 


	
 

	
(d)

	
to the best of the knowledge, information and belief of
 the Seller there are no circumstances that may result in any material adverse
 effect to the Company or the value of the Purchased Shares that are now in
 existence or may hereafter arise;


	
 

	
 

	
 


	
 

	
(e)

	
as of the Closing Date the Seller shall not be
 indebted to the Company and the Company shall not be indebted to the Seller;


	
 

	
 

	
 


	
 

	
(f)

	
the Seller does not now, nor will it prior to or on
 the Closing Date, own, either directly or indirectly, or exercise direction
 or control over any common shares of the Company other than the Purchased Shares;


	
 

	
 

	
 


	
 

	
(g)

	
the authorized capital of the Company consists of
 75,000,000 common shares, par value $0.0001, of which a total of 4,430,000
 common shares have been validly issued, are outstanding and are fully paid and non-assessable;


	
 

	
 

	
 


	
 

	
(h)

	
no person, firm or corporation has any right,
 agreement, warrant or option, present or future, contingent or absolute, or
 any right capable of becoming a right, agreement or option to require the Company to
 issue any shares in its capital or to convert any securities of the Company
 or of any other company into shares in the capital of the Company;


	
 

	
 

	
 


	
 

	
(i)

	
as of the closing, the liabilities of the Company
 whether accrued, contingent or otherwise, shall be less than $3,000.00; and the
 Seller will pay any outstanding liability of the Company with the Purchase Price


	
 

	
 

	
 


	
 

	
(j)

	
the Company does not beneficially own, directly or
 indirectly, shares in any other corporate entity;


	
 

	
 

	
 


	
 

	
(k)

	
the Company has good and marketable title to all of
 its assets, and such assets are free and clear of any financial encumbrances not
 disclosed in the Financial Statements;


	
 

	
 

	
 


	
 

	
(1)

	
the Company has filed all reports required to be filed
 by it under the Securities Act and the United States Securities Exchange
 Act of 1934, as amended (the “Exchange Act”), including pursuant to
 Section 13(a) or 15(d) of the Exchange Act, (the “SEC Reports”) on a timely basis or
 has received a valid extension of such time of filing and has filed any such SEC
 Reports prior to the expiration of any such extension. As of their respective
 dates, the SEC Reports complied in all material respects with the requirements of the
 Securities Act and the Exchange Act and the rules and regulations of the United States
 Securities and Exchange Commission (the “Commission”)
 promulgated thereunder, and none of the SEC Reports, when filed,
 contained any untrue statement of a material fact or omitted to state a
 material fact required to be stated therein or necessary in order to make





Page 2 of 5


ASPA1












	
 

	
 

	
 


	
 

	
 

	
the statements therein,
 in light of the circumstances under which they were made, not misleading. The
 financial statements of the Company included in the SEC Reports comply in all
 material respects with applicable accounting requirements and the rules and
 regulations of the Commission with respect thereto as in effect at the time
 of filing;


	
 

	
 

	
 


	
 

	
(m)

	
the Company is not a
 party to or bound by any agreement or understanding granting registration or
 anti-dilution rights to any person with respect to any of its equity or debt
 securities; no person has a right to purchase or acquire or receive any
 equity or debt security of the Company;


	
 

	
 

	
 


	
 

	
(n)

	
the Company is in
 compliance with the applicable provisions of the Sarbanes-Oxley Act of 2002
 and the rules and regulations promulgated thereunder;


	
 

	
 

	
 


	
 

	
(o)

	
contemporaneously
 herewith, the Seller as a director shall appoint a representative of the
 Buyer to the Board of Directors of the Company;


	
 

	
 

	
 


	
 

	
(p)

	
the Seller and all
 other officers and directors of the Company shall tendered their resignations
 as officers and directors of the Company, to be effective on the Closing
 Date;


	
 

	
 

	
 


	
 

	
(q)

	
the Seller agrees to
 execute and deliver such other documents and to perform such other acts as
 shall be necessary to effectuate the purposes of this Agreement; and


	
 

	
 

	
 


	
 

	
(r)

	
there are no claims
 threatened or against or affecting the Company nor are there any actions,
 suits, judgments, proceedings or investigations pending or, threatened
 against or affecting the Company, at law or in equity, before or by any
 Court, administrative agency or other tribunal or any governmental authority
 or any legal basis for same.


	
 

	
 

	
 


	
3.

	
 

	
REPRESENTATIONS
 AND WARRANTIES OF THE PURCHASER


	
 

	
 

	
 


	
3.1

	
 

	
The Purchaser
 represents and warrants to the Seller that the Purchaser:


	
 

	
 

	
 


	
 

	
(a)

	
has the legal power and
 authority to execute and deliver this Agreement and to consummate the
 transactions hereby contemplated;


	
 

	
 

	
 


	
 

	
(b)

	
understands and agrees
 that offers and sales of any of the Purchased Shares prior to the expiration
 of a period of one year after the date of completion of the transfer of the
 Purchased Shares (the “Restricted Period”) as contemplated in this Agreement
 shall only be made in compliance with the safe harbor provisions set forth in
 Rule 144, or pursuant to the registration provisions of the Securities Act or
 pursuant to an exemption therefrom, and that all offers and sales after the
 Restricted Period shall be made only in compliance with the registration
 provisions of the Securities Act or an exemption therefrom; and





Page 3 of 5


ASPA1












	
 

	
 

	
 


	
 

	
(c)

	
is acquiring the
 Purchased Shares as principal for the Purchaser’s own account, for investment
 purposes only, and not with a view to, or for, resale, distribution or
 fractionalisation thereof, in whole or in part, and no other person has a
 direct or indirect beneficial interest in the Purchased Shares


	
 

	
 


	
3.2

	
The Purchaser agrees
 not to engage in hedging transactions with regard to the Purchased Shares
 accept in compliance with the Securities Act.


	
 

	
 


	
4.

	
INDEMNIFICATION 





4.1              The
Seller hereby agrees to indemnify and hold harmless the Purchaser and the
Company against any losses, claims, damages or liabilities to which the
Purchaser or the Company may become subject insofar as such losses, claims,
damages or liabilities arise out of or are based upon taxes, real property
leases or equipment leases payable by or for which the Company has the primary
liability; and in particular, any misrepresentation of the Seller as contained
herein. Damages of the Purchaser are not limited to the amount of the Seller
received hereunder but will include the Purchaser’s or Company’s actual cost of
any claim and full costs of negotiations and for defence.


	
 

	
 


	
5.

	
POST-CLOSING
SEC REPORTS 





5.1              Except
for any Form 3, 4 or 5 to be filed on behalf of the Seller, the Purchaser
hereby agrees that it shall file any and all necessary SEC Reports, including
but not limited to any Schedule 13D, 8-K or other SEC Report.


	
 

	
 


	
6.

	
MISCELLANEOUS 





6.1              The
parties hereto acknowledge that they have obtained independent legal advice
with respect to this Agreement and acknowledge that they fully understand the
provisions of this Agreement.


6.2              Unless
otherwise provided, all dollar amounts referred to in this Agreement are in
United States dollars.


6.3              There
are no representations, warranties, collateral agreements, or conditions
concerning the subject matter of this Agreement except as herein specified.


6.4              This
Agreement will be governed by and construed in accordance with the laws of the
State of NEVADA. The parties hereby attorn to the jurisdiction of the courts
Clark County, NEVADA with respect to any legal proceedings arising from this
Agreement.


6.5              The
representations and warranties of the parties contained in this Agreement shall
survive the closing of the purchase and sale of the Purchased Shares and shall
continue in full force and effect for a period of one year.


6.7              This
Agreement may be executed in several counterparts, each of which will be deemed
to be an original and all of which will together constitute one and the same
instrument.


Page 4 of 5


ASPA1












6.8              Delivery
of an executed copy of this Agreement by electronic facsimile transmission or
other means of electronic communication capable of producing a printed copy
will be deemed to be execution and delivery of this Agreement as of the date set forth on page one of this
Agreement.


          Each
of the parties hereto has executed
this Agreement to be effective as of the day and year first above written. 


	 
	 

	SELLER:

	 

	 

	/s/ Walter Brenner
	WALTER BRENNER

	 

	PURCHASER:

	 

	TELEMEDICINE, INC.

	(Printed Name)

	 

	/s/ Matthew Palacios 
	
	 

	By:
	Matthew Palacios

	 

	Its:

	
      

    





Page 5 of 5


ASPA1